Microsoft’s Pace Of Integration Of ChatGPT Across Portfolio Impresses Analysts
Piper Sandler analyst Brent Bracelin maintained Microsoft Corp (NASDAQ:MSFT) with an Overweight and raised the price target from $247 to $290 on untapped…
Analyst Reiterates This Alzheimer’s Candidate As Top Idea For 2023
Mizuho raised the price target on BioXcel Therapeutics Inc (NASDAQ:BTAI) from $24 to $38, with a Buy rating. Since the analyst’s previous…
HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $4.5 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and maintains $4.5 price target.
Barrington Research Reiterates Outperform on DHI Group, Maintains $12 Price Target
Barrington Research analyst Gary Prestopino reiterates DHI Group (NYSE:DHX) with a Outperform and maintains $12 price target.
RBC Capital Reiterates Sector Perform on NOV, Maintains $27 Price Target
RBC Capital analyst Keith Mackey reiterates NOV (NYSE:NOV) with a Sector Perform and maintains $27 price target.
RBC Capital Reiterates Sector Perform on Aramark, Maintains $48 Price Target
RBC Capital analyst Ashish Sabadra reiterates Aramark (NYSE:ARMK) with a Sector Perform and maintains $48 price target.
Wedbush Reiterates Outperform on Uber Technologies, Maintains $38 Price Target
Wedbush analyst Daniel Ives reiterates Uber Technologies (NYSE:UBER) with a Outperform and maintains $38 price target.
Needham Reiterates Buy on Paycom Software, Maintains $450 Price Target
Needham analyst Joshua Reilly reiterates Paycom Software (NYSE:PAYC) with a Buy and maintains $450 price target.
Needham Reiterates Buy on Freshworks, Maintains $25 Price Target
Needham analyst Scott Berg reiterates Freshworks (NASDAQ:FRSH) with a Buy and maintains $25 price target.
HC Wainwright & Co. Reiterates Buy on Deciphera Pharmaceuticals, Maintains $25 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy and maintains $25 price target.